TEL: +86-21-50180596 Email: sales@biopharmaleader.com

Search

Contact Us

Tel: 0086 21 50180596

Fax: 0086 21 57758967

Mob: 0086 18721201413

E-mail:sales@biopharmaleader.com

Exhibition
Home > Exhibition > Content

Synthesis of Pharmaceutical Intermediate Products

Shanghai Biopharmaleader Co.,Ltd | Updated: Feb 28, 2017

Synthesis of pharmaceuticals and pharmaceutical intermediates in the group of antibiotics and anticancerogenic drugs

The technology has been developed to obtain (2R,3S)-3-phenylisoserine hydrochloride - an amino acid, witch is a main semi product in the synthesis of anticancer drug - Paclitaxel. The final product is characterized by 99% enantiomeric purity and 98% chemical purity.

The technology of synthesis of trans-4-cyclohexylo-S-proline has been developed in laboratory scale. trans-4-cyclohexylo-S-proline is an amino acid, which is main intermediate product in the synthesis of antihypertensive drug - Fozinopril.

Developing methods and operating conditions for synthesizing new derivatives of 5- aminolevulinic acid (ALA) and studying their application in photodynamic antitumor therapy.

developing methods for isolating food-grade flavorings and aromas and natural colorants by supercritical fluid extraction and enzymatic hydrolysis.


Shanghai Biopharmaleader Co.,Ltd is a young and innovative company specializing in the design and synthesis of organic compounds for pharmaceutical, medicinal chemistry, biotechnology, drug discovery industries and world's top universities.

We specialize in complex, multi-stage custom synthesis and process research. We are capable of supplying mg to multiple-ton quantities of key pharmaceutical intermediates and Bioactive Molecules, pre-clinical and high-throughput screening compounds, analogues, building blocks.

More information on Pharmaceutical Intermediate   http://www.biopharmaleader.net/pharmaceutical-intermediate/


Shanghai Biopharmaleader Co.,Ltd